The brain–gut-axis is an interdependent system affecting neural functions and controlling
our eating behaviour. In recent decades, neuroimaging techniques have facilitated its …

A promising new treatment approach for major depressive disorder (MDD) targets the
microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions affected …

Depression is a debilitating disorder, and at least one third of patients do not respond to
therapy. Associations between gut microbiota and depression have been observed in recent …

Background: In major depressive disorder (MDD), cognitive dysfunctions strongly contribute
to functional impairments but are barely addressed in current therapies. Novel treatment …

Background Probiotics are suggested to improve depressive symptoms via the microbiota-gut-brain
axis. We have recently shown a beneficial clinical effect of probiotic supplementation …

Over the last decade, the composition of the gut microbiota has been found to correlate with
the outcomes of cancer patients treated with immunotherapy. Accumulating evidence points …

People with Inflammatory Bowel Disease (IBD) are at risk for mental health issues, poor
sleep quality and limited engagement in physical activity (PA). Standard treatment consists of …

Digitization is considered to radically transform healthcare. As such, with seemingly
unlimited opportunities to collect data, it will play an important role in the public health policy-making …

Anhedonia has been associated with abnormal reward-related striatal dopamine functioning
in patients with different psychiatric disorders. Here, we tested whether anhedonia …

Personalised Medicine has become a reality over the last years. The emergence of ‘omics’
and big data has started revolutionizing healthcare. New ‘omics’ technologies lead to a better …